Yasuko Iwakiri
Overview
Explore the profile of Yasuko Iwakiri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
2926
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma R, Gong L, Dong C, Utsumi T, Qi J, Zhuang Z, et al.
bioRxiv
. 2025 Feb;
PMID: 39975181
Background: The liver undergoes significant hemodynamic changes during surgery, transplantation, or cirrhosis with portal hypertension(PH). The hepatic artery buffer response(HABR), which compensates for reduced portal venous flow by increasing hepatic...
2.
Jeong J, Hsu S, Horikami D, Utsumi T, Yang Y, Arefyev N, et al.
bioRxiv
. 2025 Jan;
PMID: 39868144
The liver lymphatic system plays a critical role in maintaining interstitial fluid balance and immune regulation. Efficient lymphatic drainage is essential for liver homeostasis, but its role in liver disease...
3.
Furuichi Y, Kage M, Ohta M, Ohfuji S, Sasaki H, Hidaka H, et al.
Hepatol Res
. 2024 Oct;
54(11):952-969.
PMID: 39364631
This is the English version of the guidelines for the diagnosis and treatment of idiopathic portal hypertension, extrahepatic portal obstruction, and Budd-Chiari syndrome, which were established and revised in 2018...
4.
Gong K, Xue C, Feng Z, Pan R, Wang M, Chen S, et al.
Nat Commun
. 2024 Sep;
15(1):7902.
PMID: 39256382
No abstract available.
5.
Xue C, Zeng P, Gong K, Li Q, Feng Z, Wang M, et al.
Cell Rep
. 2024 Sep;
43(9):114691.
PMID: 39235944
The strategy of lowering cholesterol levels by promoting cholesterol excretion is still lacking, and few molecular targets act on multiple cholesterol metabolic processes. In this study, we find that Nogo-B...
6.
Yanagisawa H, Maeda H, Noguchi I, Tanaka M, Wada N, Nagasaki T, et al.
Redox Biol
. 2024 Aug;
76:103314.
PMID: 39163766
Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive form of nonalcoholic fatty liver disease characterised by fat accumulation, inflammation, oxidative stress, fibrosis, and impaired liver regeneration. In this study, we found...
7.
Gong K, Xue C, Feng Z, Pan R, Wang M, Chen S, et al.
Nat Commun
. 2024 Aug;
15(1):6845.
PMID: 39122737
Glucagon-like peptide 1 (GLP1), which is mainly processed and cleaved from proglucagon in enteroendocrine cells (EECs) of the intestinal tract, acts on the GLP1 receptor in pancreatic cells to stimulate...
8.
Yang Y, Jeong J, Su T, Lai S, Zhang P, Garcia-Milian R, et al.
JHEP Rep
. 2024 Jul;
6(7):101069.
PMID: 38966234
Background & Aims: The lymphatic system plays crucial roles in maintaining fluid balance and immune regulation. Studying the liver lymphatics has been considered challenging, as common lymphatic endothelial cell (LyEC)...
9.
Gratton J, Lin M, Yu J, Weiss E, Jiang Z, Fairchild T, et al.
Cancer Cell
. 2024 May;
42(6):1127.
PMID: 38821059
No abstract available.
10.